By contrast, our data suggest that IL-18 is not important in CpG-induced MAS in young and healthy animals, since inhibition of NLRP3 or caspase-1 was able to significantly reduce plasma IL-18 levels without preventing the development of MAS. The gene discussed is CASP1; the disease is macrophage activation syndrome.